Follow The Filings

CHCT Community Healthcare Trust Inc.

Real Estate, filed as Community Healthcare Trust, Inc. (COMMON), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.0%
  • $5.9M
  • 1 reduce

In 2026 Q2 Christopher Davis trimmed Community Healthcare Trust.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Christopher Davis, Davis Selected Advisers). Not free-float ownership.

  1. Christopher Davis Reduce 0.03%

Who owns CHCT

Sorted by value, long equity only, as of 2026 Q2.

History
Christopher Davis, Davis Selected Advisers 0.03% Reduce −2.2% 322,890 $5.9M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CHCT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CHCT insider trades
  • $332K bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. David H. Dupuy CEO
    Buy
    $151K 10,000 shares at $15.13 +1.8% to stake
    Traded Aug 14 Filed Aug 17
    ↗
  2. Robert Z Hensley Director
    Buy
    $122K 8,000 shares at $15.21 +8.4% to stake
    Traded Aug 11 Filed Aug 12
    ↗
  3. Cathrine Cotman Director
    Buy
    $59K 4,000 shares at $14.66 +12% to stake
    Traded Nov 4, 2025 Filed Nov 5, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 19 stock grants and 5 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,9.01 Filing Doc
8-K/A 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 13 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $4.16M $1.22M —
Net income $7.71M -$3.18M $5.1M
Net margin * 185.3% -260.5% —

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $945.41M $992.56M $990.76M
Total equity $513.26M $475.96M $429.39M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $61.38M $58.88M $56.43M
Cash from investing -$113.68M -$92.66M -$47.7M
Cash from financing $44.86M $33.53M -$9.78M
Net change in cash -$7.44M -$0.249M -$1.04M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.